Prevalence of the metabolic syndrome in patients infected with human immunodeficiency virus [1];Prevalencia del síndrome metabólico en pacientes con infección por el virus de la inmunodeficiencia humana

Anales de Medicina Interna

Volumn 21, Issue 9, 2004, Pages 461-462

  Marcos Sanchez F ^a   Albo Castano M I ^a   Arbol Linde F ^a   Viana Alonso, A ^a   Franco Moreno, A I ^a   Casallo Blanco, S ^a  

^a HOSPITAL NUESTRA SEÑORA DEL PRADO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGED; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LETTER; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; SYNDROME DELINEATION; VIRUS INFECTION;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE;

EID: 7544251183     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Timar O, Sestier F, Levy E. Metabolic síndrome X: a review. Can J Cardiol 2000; 16: 779-789.
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
3. Fellay J, Boubaker K, Ledergerber B, Benasconi E, Furrer H, Battegay M, et al. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss VIH cohort study. Lancet 2001; 358: 1322-1327.
4. Rickerts V, Brodt H, Staszewski S, Stille W. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res 2000; 5: 329-333.
5. Behrens G, Schmidt H, Meyer S, Stoll M, Schmidt RE. Vascular complications associated with use of VIH protease inhibitors. Lancet 1998; 351: 1958-1960.
6. National Institutes of Health. Thrid report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethseda, Md. National Institutes of Health 2001.
7. Álvarez León E, Ribas Barba L, Serra Majem L. Prevalencia del síndrome metabólico en la población de la Comunidad Canada. Med Clin (Barc) 2003; 120: 172-174.